TITLE:
Ondansetron for the Treatment of Methamphetamine Dependence - 1

CONDITION:
Amphetamine-Related Disorders

INTERVENTION:
Ondansetron

SUMMARY:

      The purpose of this study is to assess ondansetron for the treatment of methamphetamine
      dependence.
    

DETAILED DESCRIPTION:

      This study was designed to be a preliminary assessment of the efficacy and safety of 3-wide
      range doses of ondansetron (0.25, 1.0 and 4.0 mg taken orally twice per day) to reduce
      methamphetamine use in subjects with methamphetamine dependence and to determine the optimal
      dose of ondansetron.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 99 Years
Criteria:

        Inclusion Criteria:

        18 years of age. Treatment seeking for meth dependence.

        Exclusion Criteria:

        Please contact site director for more details.
      
